Literature DB >> 22713705

Utility of impedance cardiography for the detection of hemodynamic changes in stable patients with sickle cell disease.

Bibhuti B Das1, Ashok Raj, Michael Recto, Maiying Kong, Salvatore Bertolone.   

Abstract

OBJECTIVES: The study sought to assess the potential utility of impedance cardiography (ICG) to detect hemodynamic changes after erythrocytapheresis in stable children with sickle cell disease (SCD).
METHODS: We prospectively monitored cardiac index, systemic vascular resistance index, heart rate, and blood pressure using ICG before and after erythrocytapheresis in 26 stable children with SCD. Echocardiography was carried out in all patients to evaluate left ventricular systolic function. Hemoglobin (Hb), sickle cell hemoglobin (HbS), and ferritin levels were also measured.
RESULTS: Of a total of 78 erythrocytapheresis procedures in 26 children with SCD, 22 (28.2%) had hypotensive episodes defined as a decrease in systolic, diastolic, or mean blood pressure by 10 mmHg. Risk factors for developing hypotension during erythrocytapheresis were identified with logistic regression analysis: lower-body surface area and decrease in cardiac index. In contrast, age, prepheresis Hb and HbS, serum ferritin levels, and left ventricular function at baseline were not associated with hypotension.
CONCLUSIONS: This study demonstrates the feasibility of the ICG technique to detect the hemodynamic changes in children with SCD after an erythrocytapheresis procedure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22713705     DOI: 10.1097/MPH.0b013e3182580300

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  1 in total

1.  Utility of Non-Invasive Monitoring of Cardiac Output and Cerebral Oximetry during Pain Management of Children with Sickle Cell Disease in the Pediatric Emergency Department.

Authors:  Pradeep Padmanabhan; Chikelue Oragwu; Bibhuti Das; John A Myers; Ashok Raj
Journal:  Children (Basel)       Date:  2018-01-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.